|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson DE, Burtness B, Leemans CR, Lui
VWY, Bauman JE and Grandis JR: Head and neck squamous cell
carcinoma. Nat Rev Dis Primers. 6:922020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roh JL, Kim EH, Jang HJ, Park JY and Shin
D: Induction of ferroptotic cell death for overcoming cisplatin
resistance of head and neck cancer. Cancer Lett. 381:96–103. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gorrini C, Harris IS and Mak TW:
Modulation of oxidative stress as an anticancer strategy. Nat Rev
Drug Discov. 12:931–947. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen X, Comish PB, Tang D and Kang R:
Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol.
9:6371622021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Masaldan S, Belaidi AA, Ayton S and Bush
AI: Cellular senescence and iron dyshomeostasis in Alzheimer's
disease. Pharmaceuticals (Basel). 12:932019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guan X, Li X, Yang X, Yan J, Shi P, Ba L,
Cao Y and Wang P: The neuroprotective effects of carvacrol on
ischemia/reperfusion-induced hippocampal neuronal impairment by
ferroptosis mitigation. Life Sci. 235:1167952019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lv Z, Han J, Li J, Guo H, Fei Y, Sun Z,
Dong J, Wang M, Fan C, Li W, et al: Single cell RNA-seq analysis
identifies ferroptotic chondrocyte cluster and reveals TRPV1 as an
anti-ferroptotic target in osteoarthritis. EBioMedicine.
84:1042582022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lei G, Zhuang L and Gan B: Targeting
ferroptosis as a vulnerability in cancer. Nat Rev Cancer.
22:381–396. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang WS and Stockwell BR: Synthetic lethal
screening identifies compounds activating iron-dependent,
nonapoptotic cell death in oncogenic-RAS-harboring cancer cells.
Chem Biol. 15:234–245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stockwell BR, Jiang X and Gu W: Emerging
mechanisms and disease relevance of ferroptosis. Trends Cell Biol.
30:478–490. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi
AA and Lei P: Ferroptosis: Mechanisms and links with diseases.
Signal Transduct Target Ther. 6:492021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang W and Ferrara N: Iron metabolism in
the tumor microenvironment: Contributions of innate immune cells.
Front Immunol. 11:6268122021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen Z, Song J, Yung BC, Zhou Z, Wu A and
Chen X: Emerging strategies of cancer therapy based on ferroptosis.
Adv Mater. 30:e17040072018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He YJ, Liu XY, Xing L, Wan X, Chang X and
Jiang HL: Fenton reaction-independent ferroptosis therapy via
glutathione and iron redox couple sequentially triggered lipid
peroxide generator. Biomaterials. 241:1199112020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Manz DH, Blanchette NL, Paul BT, Torti FM
and Torti SV: Iron and cancer: Recent insights. Ann N Y Acad Sci.
1368:149–161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Galaris D, Barbouti A and Pantopoulos K:
Iron homeostasis and oxidative stress: An intimate relationship.
Biochim Biophys Acta Mol Cell Res. 1866:1185352019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Y, Lin Y, Wang M, Yuan K, Wang Q, Mu
P, Du J, Yu Z, Yang S, Huang K, et al: Targeting ferroptosis
suppresses osteocyte glucolipotoxicity and alleviates diabetic
osteoporosis. Bone Res. 10:262022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koppula P, Zhuang L and Gan B: Cystine
transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient
dependency, and cancer therapy. Protein Cell. 12:599–620. 2021.
View Article : Google Scholar :
|
|
22
|
Tan Y, Huang Y, Mei R, Mao F, Yang D, Liu
J, Xu W, Qian H and Yan Y: HucMSC-derived exosomes delivered BECN1
induces ferroptosis of hepatic stellate cells via regulating the
xCT/GPX4 axis. Cell Death Dis. 13:3192022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maiorino M, Conrad M and Ursini F: GPx4,
lipid peroxidation, and cell death: Discoveries, rediscoveries, and
open issues. Antioxid Redox Signal. 29:61–74. 2018. View Article : Google Scholar
|
|
24
|
Seibt TM, Proneth B and Conrad M: Role of
GPX4 in ferroptosis and its pharmacological implication. Free Radic
Biol Med. 133:144–152. 2019. View Article : Google Scholar
|
|
25
|
Luo C, Sun J, Liu D, Sun B, Miao L,
Musetti S, Li J, Han X, Du Y, Li L, et al: Self-assembled redox
dual-responsive prodrug-nano-system formed by single
thioether-bridged paclitaxel-fatty acid conjugate for cancer
chemotherapy. Nano Lett. 16:5401–5408. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Y, Karakhanova S, Hartwig W, D'Haese
JG, Philippov PP, Werner J and Bazhin AV: Mitochondria and
mitochondrial ROS in cancer: Novel targets for anticancer therapy.
J Cell Physiol. 231:2570–2581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang WS and Stockwell BR: Ferroptosis:
Death by lipid peroxidation. Trends Cell Biol. 26:165–176. 2016.
View Article : Google Scholar :
|
|
28
|
Lee JY, Kim WK, Bae KH, Lee SC and Lee EW:
Lipid metabolism and ferroptosis. Biology (Basel).
10:1842021.PubMed/NCBI
|
|
29
|
Lee H, Zandkarimi F, Zhang Y, Meena JK,
Kim J, Zhuang L, Tyagi S, Ma L, Westbrook TF, Steinberg GR, et al:
Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat
Cell Biol. 22:225–234. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar :
|
|
31
|
Liu J, Kang R and Tang D: Signaling
pathways and defense mechanisms of ferroptosis. FEBS J.
289:7038–7050. 2022. View Article : Google Scholar
|
|
32
|
Gan B: ACSL4, PUFA, and ferroptosis: New
arsenal in anti-tumor immunity. Signal Transduct Target Ther.
7:1282022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hung CC, Chien CY, Chu PY, Wu YJ, Lin CS,
Huang CJ, Chan LP, Wang YY, Yuan SF, Hour TC and Chen JY:
Differential resistance to platinum-based drugs and 5-fluorouracil
in p22phox-overexpressing oral squamous cell carcinoma:
Implications of alternative treatment strategies. Head Neck.
39:1621–1630. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kallunki T, Olsen OD and Jäättelä M:
Cancer-associated lysosomal changes: Friends or foes? Oncogene.
32:1995–2004. 2013. View Article : Google Scholar
|
|
35
|
Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X,
Yang T, Yang YX, Wang D, Qiu JX and Zhou SF: Plumbagin induces G2/M
arrest, apoptosis, and autophagy via p38 MAPK- and
PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell
carcinoma cells. Drug Des Devel Ther. 9:1601–1626. 2015.PubMed/NCBI
|
|
36
|
Chen X, Kang R, Kroemer G and Tang D:
Broadening horizons: The role of ferroptosis in cancer. Nat Rev
Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu W, Chen Y, Putluri N, Coarfa C,
Robertson MJ, Putluri V, Stossi F, Dubrulle J, Mancini MA, Pang JC,
et al: Acquisition of cisplatin resistance shifts head and neck
squamous cell carcinoma metabolism toward neutralization of
oxidative stress. Cancers (Basel). 12:16702020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han L, Li L and Wu G: Induction of
ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1
potentiates cisplatin responsiveness in OSCC cells. Mol Cell
Probes. 64:1018212022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu B, Chen XB, Ying MD, He QJ, Cao J and
Yang B: The role of ferroptosis in cancer development and treatment
response. Front Pharmacol. 8:9922018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Feng H and Stockwell BR: Unsolved
mysteries: How does lipid peroxidation cause ferroptosis? PLoS
Biol. 16:e20062032018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hu K, Li K, Lv J, Feng J, Chen J, Wu H,
Cheng F, Jiang W, Wang J, Pei H, et al: Suppression of the
SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant
lung adenocarcinoma. J Clin Invest. 130:1752–1766. 2020. View Article : Google Scholar :
|
|
42
|
Ji X, Qian J, Rahman SMJ, Siska PJ, Zou Y,
Harris BK, Hoeksema MD, Trenary IA, Heidi C, Eisenberg R, et al:
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small
cell lung cancer progression. Oncogene. 37:5007–5019. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ma Z, Zhang H, Lian M, Yue C, Dong G, Jin
Y, Li R, Wan H, Wang R, Wang Y, et al: SLC7A11, a component of
cysteine/glutamate transporter, is a novel biomarker for the
diagnosis and prognosis in laryngeal squamous cell carcinoma. Oncol
Rep. 38:3019–3029. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hémon A, Louandre C, Lailler C, Godin C,
Bottelin M, Morel V, François C, Galmiche A and Saidak Z: SLC7A11
as a biomarker and therapeutic target in HPV-positive head and neck
squamous cell carcinoma. Biochem Biophys Res Commun. 533:1083–1087.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jyotsana N, Ta KT and DelGiorno KE: The
role of cystine/glutamate antiporter SLC7A11/xCT in the
pathophysiology of cancer. Front Oncol. 12:8584622022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Slaby O, Laga R and Sedlacek O:
Therapeutic targeting of non-coding RNAs in cancer. Biochem J.
474:4219–4251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xie B and Guo Y: Molecular mechanism of
cell ferroptosis and research progress in regulation of ferroptosis
by noncoding RNAs in tumor cells. Cell Death Discov. 7:1012021.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Luo M, Wu L, Zhang K, Wang H, Zhang T,
Gutierrez L, O'Connell D, Zhang P, Li Y, Gao T, et al: miR-137
regulates ferroptosis by targeting glutamine transporter SLC1A5 in
melanoma. Cell Death Differ. 25:1457–1472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang K, Wu L, Zhang P, Luo M, Du J, Gao
T, O'Connell D, Wang G, Wang H and Yang Y: miR-9 regulates
ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in
melanoma. Mol Carcinog. 57:1566–1576. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Quirico L, Orso F, Cucinelli S, Paradzik
M, Natalini D, Centonze G, Dalmasso A, La Vecchia S, Coco M,
Audrito V, et al: miRNA-guided reprogramming of glucose and
glutamine metabolism and its impact on cell adhesion/migration
during solid tumor progression. Cell Mol Life Sci. 79:2162022.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang J, Wang B, Ren H and Chen W: miR-9-5p
inhibits pancreatic cancer cell proliferation, invasion and
glutamine metabolism by targeting GOT1. Biochem Biophys Res Commun.
509:241–218. 2019. View Article : Google Scholar
|
|
52
|
Tomita K, Fukumoto M, Itoh K, Kuwahara Y,
Igarashi K, Nagasawa T, Suzuki M, Kurimasa A and Sato T: MiR-7-5p
is a key factor that controls radioresistance via intracellular
Fe2+ content in clinically relevant radioresistant cells. Biochem
Biophys Res Commun. 518:712–718. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tomita K, Kuwahara Y, Takashi Y, Igarashi
K, Nagasawa T, Nabika H, Kurimasa A, Fukumoto M, Nishitani Y and
Sato T: Clinically relevant radioresistant cells exhibit resistance
to H2O2 by decreasing internal
H2O2 and lipid peroxidation. Tumour Biol.
40:10104283187992502018. View Article : Google Scholar
|
|
54
|
Amaral AJ, Andrade J, Foxall RB, Matoso P,
Matos AM, Soares RS, Rocha C, Ramos CG, Tendeiro R, Serra-Caetano
A, et al: miRNA profiling of human naive CD4 T cells links
miR-34c-5p to cell activation and HIV replication. EMBO J.
36:346–360. 2017. View Article : Google Scholar
|
|
55
|
Zhang B, Li Y, Hou D, Shi Q, Yang S and Li
Q: MicroRNA-375 inhibits growth and enhances radiosensitivity in
oral squamous cell carcinoma by targeting insulin like growth
factor 1 receptor. Cell Physiol Biochem. 42:2105–2117. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang K, Jin J, Ma T and Zhai H: MiR-139-5p
inhibits the tumorigenesis and progression of oral squamous
carcinoma cells by targeting HOXA9. J Cell Mol Med. 21:3730–3740.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shen Y, Sun C, Zhao B, Guo H, Li J, Xia Y,
Liu M, Piao S and Saiyin W: miR-34c-5p mediates the cellular
malignant behaviors of oral squamous cell carcinoma through
targeted binding of TRIM29. Ann Transl Med. 9:15372021. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sun K, Ren W, Li S, Zheng J, Huang Y, Zhi
K and Gao L: MiR-34c-3p upregulates erastin-induced ferroptosis to
inhibit proliferation in oral squamous cell carcinomas by targeting
SLC7A11. Pathol Res Pract. 231:1537782022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Garikipati VNS, Verma SK, Cheng Z, Liang
D, Truongcao MM, Cimini M, Yue Y, Huang G, Wang C, Benedict C, et
al: Circular RNA CircFndc3b modulates cardiac repair after
myocardial infarction via FUS/VEGF-A axis. Nat Commun. 10:43172019.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Balihodzic A, Prinz F, Dengler MA, Calin
GA, Jost PJ and Pichler M: Non-coding RNAs and ferroptosis:
Potential implications for cancer therapy. Cell Death Differ.
29:1094–1106. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang X, Wang L, Li H, Zhang L, Zheng X
and Cheng W: Crosstalk between noncoding RNAs and ferroptosis: New
dawn for overcoming cancer progression. Cell Death Dis. 11:5802020.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yang J, Cao XH, Luan KF and Huang YD:
Circular RNA FNDC3B protects oral squamous cell carcinoma cells
from ferroptosis and contributes to the malignant progression by
regulating miR-520d-5p/SLC7A11 axis. Front Oncol. 11:6727242021.
View Article : Google Scholar
|
|
63
|
Ayala A, Muñoz MF and Argüelles S: Lipid
peroxidation: Production, metabolism, and signaling mechanisms of
malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev.
2014:3604382014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Song X and Long D: Nrf2 and ferroptosis: A
new research direction for neurodegenerative diseases. Front
Neurosci. 14:2672020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zhang Q, Qu H, Chen Y, Luo X, Chen C, Xiao
B, Ding X, Zhao P, Lu Y, Chen AF and Yu Y: Atorvastatin induces
mitochondria-dependent ferroptosis via the modulation of
Nrf2-xCT/GPx4 axis. Front Cell Dev Biol. 10:8060812022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ma Q: Role of nrf2 in oxidative stress and
toxicity. Annu Rev Pharmacol Toxicol. 53:401–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Jelic MD, Mandic AD, Maricic SM and
Srdjenovic BU: Oxidative stress and its role in cancer. J Cancer
Res Ther. 17:22–28. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu
C and Li B: SLC7A11 regulated by NRF2 modulates esophageal squamous
cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl
Med. 19:3672021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yang J, Mo J, Dai J, Ye C, Cen W, Zheng X,
Jiang L and Ye L: Cetuximab promotes RSL3-induced ferroptosis by
suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant
colorectal cancer. Cell Death Dis. 12:10792021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Sánchez-Ortega M, Carrera AC and Garrido
A: Role of NRF2 in lung cancer. Cells. 10:18792021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Farkhondeh T, Pourbagher-Shahri AM,
Azimi-Nezhad M, Forouzanfar F, Brockmueller A, Ashrafizadeh M,
Talebi M, Shakibaei M and Samarghandian S: Roles of Nrf2 in gastric
cancer: Targeting for therapeutic strategies. Molecules.
26:31572021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Tossetta G, Fantone S, Montanari E,
Marzioni D and Goteri G: Role of NRF2 in ovarian cancer.
Antioxidants (Basel). 11:6632022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wang XJ, Sun Z, Villeneuve NF, Zhang S,
Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak GT, et al: Nrf2
enhances resistance of cancer cells to chemotherapeutic drugs, the
dark side of Nrf2. Carcinogenesis. 29:1235–1243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ying J, Qiu X, Lu Y and Zhang M: SOCS1 and
its potential clinical role in tumor. Pathol Oncol Res.
25:1295–1301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Hu ZW, Wen YH, Ma RQ, Chen L, Zeng XL, Wen
WP and Sun W: Ferroptosis driver SOCS1 and suppressor FTH1
independently correlate with M1 and M2 macrophage infiltration in
head and neck squamous cell carcinoma. Front Cell Dev Biol.
9:7277622021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Lee CH, Chang JS, Syu SH, Wong TS, Chan
JY, Tang YC, Yang ZP, Yang WC, Chen CT, Lu SC, et al: IL-1β
promotes malignant transformation and tumor aggressiveness in oral
cancer. J Cell Physiol. 230:875–884. 2015. View Article : Google Scholar
|
|
77
|
Zhao J, Dar HH, Deng Y, St Croix CM, Li Z,
Minami Y, Shrivastava IH, Tyurina YY, Etling E, Rosenbaum JC, et
al: PEBP1 acts as a rheostat between prosurvival autophagy and
ferroptotic death in asthmatic epithelial cells. Proc Natl Acad Sci
USA. 117:14376–14385. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Li M, Jin S, Zhang Z, Ma H and Yang X:
Interleukin-6 facilitates tumor progression by inducing ferroptosis
resistance in head and neck squamous cell carcinoma. Cancer Lett.
527:28–40. 2022. View Article : Google Scholar
|
|
79
|
Jin S, Yang X, Li J, Yang W, Ma H and
Zhang Z: p53-targeted lincRNA-p21 acts as a tumor suppressor by
inhibiting JAK2/STAT3 signaling pathways in head and neck squamous
cell carcinoma. Mol Cancer. 18:382019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ding Y, Chen X, Liu C, Ge W, Wang Q, Hao
X, Wang M, Chen Y and Zhang Q: Identification of a small molecule
as inducer of ferroptosis and apoptosis through ubiquitination of
GPX4 in triple negative breast cancer cells. J Hematol Oncol.
14:192021. View Article : Google Scholar
|
|
81
|
Zhao L, Peng Y, He S, Li R, Wang Z, Huang
J, Lei X, Li G and Ma Q: Apatinib induced ferroptosis by lipid
peroxidation in gastric cancer. Gastric Cancer. 24:642–654. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Liu CC, Li HH, Lin JH, Chiang MC, Hsu TW,
Li AF, Yen DH, Hsu HS and Hung SC: Esophageal cancer stem-like
cells resist ferroptosis-induced cell death by active Hsp27-GPX4
pathway. Biomolecules. 12:482021. View Article : Google Scholar
|
|
83
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Chatterjee R and Chatterjee J: ROS and
oncogenesis with special reference to EMT and stemness. Eur J Cell
Biol. 99:1510732020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Cheng FZY, Wang X, Dou J and Wu Z:
Research progress on the role and mechanism of GPX4 in ferroptosis.
Mod Oncol. 29:1254–1258. 2021.
|
|
86
|
Viswanathan VS, Ryan MJ, Dhruv HD, Gill S,
Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada
K, Aguirre AJ, et al: Dependency of a therapy-resistant state of
cancer cells on a lipid peroxidase pathway. Nature. 547:453–457.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Hangauer MJ, Viswanathan VS, Ryan MJ, Bole
D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL,
et al: Drug-tolerant persister cancer cells are vulnerable to GPX4
inhibition. Nature. 551:247–250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lee JR, Roh JL, Lee SM, Park Y, Cho KJ,
Choi SH, Nam SY and Kim SY: Overexpression of glutathione
peroxidase 1 predicts poor prognosis in oral squamous cell
carcinoma. J Cancer Res Clin Oncol. 143:2257–2265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Fukuda M, Ogasawara Y, Hayashi H, Okuyama
A, Shiono J, Inoue K and Sakashita H: Down-regulation of
glutathione peroxidase 4 in oral cancer inhibits tumor growth
through SREBP1 signaling. Anticancer Res. 41:1785–1792. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Ye J, Jiang X, Dong Z, Hu S and Xiao M:
Low-concentration PTX and RSL3 inhibits tumor cell growth
synergistically by inducing ferroptosis in mutant p53
hypopharyngeal squamous carcinoma. Cancer Manag Res. 11:9783–9792.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Ahmat Amin MKB, Shimizu A and Ogita H: The
pivotal roles of the epithelial membrane protein family in cancer
invasiveness and metastasis. Cancers (Basel). 11:16202019.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Liu Y, Ding Y, Nie Y and Yang M: EMP1
promotes the proliferation and invasion of ovarian cancer cells
through activating the MAPK pathway. Onco Targets Ther.
13:2047–2055. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Durgan J, Tao G, Walters MS, Florey O,
Schmidt A, Arbelaez V, Rosen N, Crystal RG and Hall A: SOS1 and Ras
regulate epithelial tight junction formation in the human airway
through EMP1. EMBO Rep. 16:87–96. 2015. View Article : Google Scholar :
|
|
94
|
Sun GG, Wang YD, Cui DW, Cheng YJ and Hu
WN: EMP1 regulates caspase-9 and VEGFC expression and suppresses
prostate cancer cell proliferation and invasion. Tumour Biol.
35:3455–3462. 2014. View Article : Google Scholar
|
|
95
|
Wang Y, Zhang L, Yao C, Ma Y and Liu Y:
Epithelial membrane protein 1 promotes sensitivity to RSL3-induced
ferroptosis and intensifies gefitinib resistance in head and neck
cancer. Oxid Med Cell Longev. 2022:47506712022.PubMed/NCBI
|
|
96
|
van Zandwijk N: Tolerability of gefitinib
in patients receiving treatment in everyday clinical practice. Br J
Cancer. 89(Suppl 2): S9–S14. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Liu Y, Hao J, Yuan G, Wei M, Bu Y, Jin T
and Ma L: PER1 as a tumor suppressor attenuated in the malignant
phenotypes of breast cancer cells. Int J Gen Med. 14:7077–7087.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Chakrabarti S and Michor F: Circadian
clock effects on cellular proliferation: Insights from theory and
experiments. Curr Opin Cell Biol. 67:17–26. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zhao H, Zeng ZL, Yang J, Jin Y, Qiu MZ, Hu
XY, Han J, Liu KY, Liao JW and Zou QF: Prognostic relevance of
Period1 (Per1) and Period2 (Per2) expression in human gastric
cancer. Int J Clin Exp Pathol. 7:619–630. 2014.PubMed/NCBI
|
|
100
|
Krugluger W, Brandstaetter A, Kállay E,
Schueller J, Krexner E, Kriwanek S, Bonner E and Cross HS:
Regulation of genes of the circadian clock in human colon cancer:
reduced period-1 and dihydropyrimidine dehydrogenase transcription
correlates in high-grade tumors. Cancer Res. 67:7917–7922. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Hsu CM, Lin SF, Lu CT, Lin PM and Yang MY:
Altered expression of circadian clock genes in head and neck
squamous cell carcinoma. Tumour Biol. 33:149–155. 2012. View Article : Google Scholar
|
|
102
|
Liu B, Xu K, Jiang Y and Li X: Aberrant
expression of Per1, Per2 and Per3 and their prognostic relevance in
non-small cell lung cancer. Int J Clin Exp Pathol. 7:7863–7871.
2014.
|
|
103
|
Gery S, Komatsu N, Baldjyan L, Yu A, Koo D
and Koeffler HP: The circadian gene per1 plays an important role in
cell growth and DNA damage control in human cancer cells. Mol Cell.
22:375–382. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Yang G, Yang Y, Tang H and Yang K: Loss of
the clock gene Per1 promotes oral squamous cell carcinoma
progression via the AKT/mTOR pathway. Cancer Sci. 111:1542–1554.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Yang Y, Tang H, Zheng J and Yang K: The
PER1/HIF-1alpha negative feedback loop promotes ferroptosis and
inhibits tumor progression in oral squamous cell carcinoma. Transl
Oncol. 18:1013602022. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Chen D and Che G: Value of caveolin-1 in
cancer progression and prognosis: Emphasis on cancer-associated
fibroblasts, human cancer cells and mechanism of caveolin-1
expression (Review). Oncol Lett. 8:1409–1421. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Yang G, Goltsov AA, Ren C, Kurosaka S,
Edamura K, Logothetis R, DeMayo FJ, Troncoso P, Blando J,
DiGiovanni J and Thompson TC: Caveolin-1 upregulation contributes
to c-Myc-induced high-grade prostatic intraepithelial neoplasia and
prostate cancer. Mol Cancer Res. 10:218–229. 2012. View Article : Google Scholar
|
|
108
|
Sun J, Lu Y, Yu C, Xu T, Nie G, Miao B and
Zhang X: Involvement of the TGF-β1 pathway in caveolin-1-associated
regulation of head and neck tumor cell metastasis. Oncol Lett.
19:1298–1304. 2020.PubMed/NCBI
|
|
109
|
Nwosu ZC, Ebert MP, Dooley S and Meyer C:
Caveolin-1 in the regulation of cell metabolism: A cancer
perspective. Mol Cancer. 15:712016. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Vered M, Lehtonen M, Hotakainen L, Pirilä
E, Teppo S, Nyberg P, Sormunen R, Zlotogorski-Hurvitz A, Salo T and
Dayan D: Caveolin-1 accumulation in the tongue cancer tumor
microenvironment is significantly associated with poor prognosis:
An in-vivo and in-vitro study. BMC Cancer. 15:252015. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Deng G, Li Y, Ma S, Gao Z, Zeng T, Chen L,
Ye H, Yang M, Shi H, Yao X, et al: Caveolin-1 dictates ferroptosis
in the execution of acute immune-mediated hepatic damage by
attenuating nitrogen stress. Free Radic Biol Med. 148:151–161.
2020. View Article : Google Scholar
|
|
112
|
Lu T, Zhang Z, Pan X, Zhang J, Wang X,
Wang M, Li H, Yan M and Chen W: Caveolin-1 promotes cancer
progression via inhibiting ferroptosis in head and neck squamous
cell carcinoma. J Oral Pathol Med. 51:52–62. 2022. View Article : Google Scholar
|
|
113
|
Hu ZW, Chen L, Ma RQ, Wei FQ, Wen YH, Zeng
XL, Sun W and Wen WP: Comprehensive analysis of ferritin subunits
expression and positive correlations with tumor-associated
macrophages and T regulatory cells infiltration in most solid
tumors. Aging (Albany NY). 13:11491–11506. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Salatino A, Aversa I, Battaglia AM, Sacco
A, Di Vito A, Santamaria G, Chirillo R, Veltri P, Tradigo G, Di
Cello A, et al: H-ferritin affects cisplatin-induced cytotoxicity
in ovarian cancer cells through the modulation of ROS. Oxid Med
Cell Longev. 2019:34612512019. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Black W, Chen Y, Matsumoto A, Thompson DC,
Lassen N, Pappa A and Vasiliou V: Molecular mechanisms of
ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal.
Free Radic Biol Med. 52:1937–1944. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Okazaki S, Shintani S, Hirata Y, Suina K,
Semba T, Yamasaki J, Umene K, Ishikawa M, Saya H and Nagano O:
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT
inhibitors in glutathione deficiency-resistant cancer cells.
Oncotarget. 9:33832–33843. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Yardley DA: Taxanes in the elderly patient
with metastatic breast cancer. Breast Cancer (Dove Med Press).
7:293–301. 2015.PubMed/NCBI
|
|
118
|
Choi YH and Yoo YH: Taxol-induced growth
arrest and apoptosis is associated with the upregulation of the Cdk
inhibitor, p21WAF1/CIP1, in human breast cancer cells. Oncol Rep.
28:2163–2169. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Lv C, Qu H, Zhu W, Xu K, Xu A, Jia B, Qing
Y, Li H, Wei HJ and Zhao HY: Low-dose paclitaxel inhibits tumor
cell growth by regulating glutaminolysis in colorectal carcinoma
cells. Front Pharmacol. 8:2442017. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Shen YA, Li WH, Chen PH, He CL, Chang YH
and Chuang CM: Intraperitoneal delivery of a novel
liposome-encapsulated paclitaxel redirects metabolic reprogramming
and effectively inhibits cancer stem cells in
Taxol(®)-resistant ovarian cancer. Am J Transl Res.
7:841–855. 2015.
|
|
121
|
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao
N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell
Death Dis. 11:882020. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Lin L, Song C, Wei Z, Zou H, Han S, Cao Z,
Zhang X, Zhang G, Ran J, Cai Y and Han W: Multifunctional
photodynamic/photothermal nano-agents for the treatment of oral
leukoplakia. J Nanobiotechnology. 20:1062022. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Gurudath S, Ganapathy K, D S, Pai A,
Ballal S and Ml A: Estimation of superoxide dismutase and
glutathione peroxidase in oral submucous fibrosis, oral leukoplakia
and oral cancer-a comparative study. Asian Pac J Cancer Prev.
13:4409–4412. 2012. View Article : Google Scholar
|
|
124
|
Zhu T, Shi L, Yu C, Dong Y, Qiu F, Shen L,
Qian Q, Zhou G and Zhu X: Ferroptosis promotes photodynamic
therapy: Supramolecular photosensitizer-inducer nanodrug for
enhanced cancer treatment. Theranostics. 9:3293–3307. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Liang F, Wang R, Du Q and Zhu S: An
epithelial-mesenchymal transition hallmark gene-based risk score
system in head and neck squamous-cell carcinoma. Int J Gen Med.
14:4219–4227. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG and
Gao LC: System Xc −/GSH/GPX4 axis: An
important antioxidant system for the ferroptosis in drug-resistant
solid tumor therapy. Front Pharmacol. 13:9102922022. View Article : Google Scholar
|
|
128
|
Dodson M, Castro-Portuguez R and Zhang DD:
NRF2 plays a critical role in mitigating lipid peroxidation and
ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Tang Y, Li C, Zhang YJ and Wu ZH:
Ferroptosis-related long non-coding RNA signature predicts the
prognosis of head and neck squamous cell carcinoma. Int J Biol Sci.
17:702–711. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee
H, Koppula P, Wu S, Zhuang L, Fang B, et al: DHODH-mediated
ferroptosis defence is a targetable vulnerability in cancer.
Nature. 593:586–590. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Hassannia B, Vandenabeele P and Vanden
Berghe T: Targeting ferroptosis to iron out cancer. Cancer Cell.
35:830–849. 2019. View Article : Google Scholar : PubMed/NCBI
|
